Cargando…
Comparing single‐target and multitarget approaches for postoperative circulating tumour DNA detection in stage II–III colorectal cancer patients
Circulating tumour DNA (ctDNA) detection for postoperative risk stratification in cancer patients has great clinical potential. However, low ctDNA abundances complicates detection. Multitarget (MT) detection strategies have been developed to increase sensitivity. Yet, empirical evidence supporting p...
Autores principales: | Henriksen, Tenna Vesterman, Reinert, Thomas, Rasmussen, Mads Heilskov, Demuth, Christina, Løve, Uffe Schou, Madsen, Anders Husted, Gotschalck, Kåre Andersson, Iversen, Lene Hjerrild, Andersen, Claus Lindbjerg |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9580876/ https://www.ncbi.nlm.nih.gov/pubmed/35895438 http://dx.doi.org/10.1002/1878-0261.13294 |
Ejemplares similares
-
Impact of Whole Genome Doubling on Detection of Circulating Tumor DNA in Colorectal Cancer
por: Kabel, Jonas, et al.
Publicado: (2023) -
Validation of computational determination of microsatellite status using whole exome sequencing data from colorectal cancer patients
por: Johansen, Amanda Frydendahl Boll, et al.
Publicado: (2019) -
Incidence of Recurrence and Time to Recurrence in Stage I to III Colorectal Cancer: A Nationwide Danish Cohort Study
por: Nors, Jesper, et al.
Publicado: (2023) -
Circulating Tumor DNA in Stage III Colorectal Cancer, beyond Minimal Residual Disease Detection, toward Assessment of Adjuvant Therapy Efficacy and Clinical Behavior of Recurrences
por: Henriksen, Tenna Vesterman, et al.
Publicado: (2022) -
Novel DNA methylation biomarkers show high sensitivity and specificity for blood-based detection of colorectal cancer—a clinical biomarker discovery and validation study
por: Jensen, Sarah Østrup, et al.
Publicado: (2019)